F2 Gene (Prothrombin G20210A) Thrombophilia Genetic Test in Dubai, UAE

Executive Summary & Core Metrics

✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing and dual‑bioinformatics verification.
✓Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
✓Clinical Guidance: Complimentary tele‑post‑test guidance on result interpretation from a clinical consultant.
✓Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The F2 Gene (Prothrombin) G20210A Mutation NGS Test identifies the most common inherited thrombophilia, enabling precise risk stratification for venous thromboembolism. This test utilizes next-generation sequencing to analyze the full coding region of the F2 gene, detecting the classic G20210A mutation as well as any rare or novel variants that may contribute to thrombotic risk.

Feature	Our NGS Test	Closest Alternative (PCR)
Methodology	Next‑Generation Sequencing – Full F2 gene analysis	Targeted PCR for G20210A only
Analytical Sensitivity	>99.9% (detects known and novel variants)	~98% (misses rare or compound mutations)
Turnaround Time	3–4 Weeks (comprehensive report)	5–7 Working Days
Clinical Utility	Superior for familial screening & research‑grade resolution	Adequate for direct mutation confirmation

Physician Insight & Safety Protocols

"As a Consultant Medical Genetics, I emphasize that the F2 G20210A mutation is a common hereditary risk factor for venous thromboembolism, but a positive result alone does not define a clinical outcome. Comprehensive evaluation integrates genetic findings with personal and family thrombotic history for precise, individualized risk management. Anticoagulation therapy adjustment must always be guided by a specialist."

— Dr. Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Advisory Guidelines

⚠️ Do not discontinue or alter prescribed anticoagulant medication without consulting your treating physician. This genetic test is an adjunctive tool and does not replace a complete clinical thrombophilia evaluation or specialist hematology assessment.

Exclusion Criteria & Emergency Indicators

Exclusion Criteria: Active malignancy under treatment, known liver disease with coagulopathy, acute inflammatory states that may transiently affect coagulation parameters.
ER Red Flags: Sudden unilateral leg pain/swelling, pleuritic chest pain, unexplained dyspnoea, or haemoptysis demand immediate emergency evaluation regardless of genetic status.

Patient FAQ & Clinical Guidance

1. What does the F2 Gene Thrombophilia NGS test detect?

It detects the Prothrombin G20210A mutation, the most prevalent genetic risk factor for venous thromboembolism, and provides comprehensive analysis of the entire coding region of the F2 gene using next-generation sequencing for maximum accuracy.

2. How should I prepare for the test and what sample is needed?

No fasting is required. Acceptable specimen types include whole blood (EDTA), extracted DNA, or a single drop of blood on an FTA card. Our VIP Mobile Phlebotomy service ensures professional collection at your convenience between 8 AM and 11 PM.

3. When will I receive my results and who will explain them?

Results are available within 3 to 4 weeks via a comprehensive clinical report. A board-certified genetics consultant provides a complimentary tele-guidance session to help interpret your genetic risk profile and its implications for your health management.

UAE Regulatory & Data Privacy Adherence

Regulatory Framework: DNA Labs UAE strictly operates in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed, stored, and transmitted under strict encryption and access control protocols to ensure absolute patient confidentiality and regulatory adherence.

Clinical & Logistical Metadata

Test Name	F2 Gene (Prothrombin G20210A) Thrombophilia Genetic Test
Price (AED)	2,800 AED
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Whole Blood (EDTA), Extracted DNA, or FTA Card
Methodology Used	Next‑Generation Sequencing (NGS)
ICD-10-CM Code	D68.5
LOINC Code	33956-8
DHA License & Address	DHA License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE